Drug Trial Radar · NCT07395232
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
153
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Mar 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Dompé Farmaceutici S.p.AIndustry
- Sponsor type
- Industry
- First posted
- Feb 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 compared with vehicle ophthalmic solution, in participants with AKC. The study consists of 2 cohorts: the adult cohort includes approximately 138 participants and the pediatric cohort which includes approximately 15 participants. The cohorts will be randomized separately. Adult participants will be randomized in a 1:1 ratio, while pediatric participants will be randomized in a 2:1 ratio to receive DFL24498 or vehicle.
Conditions
- Atopic Keratoconjunctivitis
Interventions
DFL24498Drug
DFL24498 will be instilled in each eye for 12 Weeks.
VehicleDrug
Vehicle eye drops without active drug will be instilled in each eye for 12 Weeks.
dexamethasone sodium phosphate (DSP) ophthalmic solutionDrug
Rescue medication may be administered as required at the Investigator discretion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline at week 6 in ocular itching score assessed by visual analog scale (VAS).Time frame: Baseline and at Week 6
Locations
19 sites in 3 countries. Site status is shown where the registry gives one.
Bowden Eye Associates - Southside Location
Jacksonville, Florida · Recruiting
University of Miami, Miller School of Medicine, Bascom Palmer Eye Institute
Miami, Florida · Recruiting
Clayton Eye Clinical Research
Morrow, Georgia · Recruiting
Ophthalmology Associates
St Louis, Missouri · Recruiting
NYU Langone Health - Eye Center
New York, New York · Recruiting
Duke Eye Center - Ophthalmology
Durham, North Carolina · Recruiting
Total Eye Care, PA
Memphis, Tennessee · Recruiting
Baylor University Jamail Specialty Care Center- Alkek Eye Center- Ophthalmology
Houston, Texas · Recruiting
IRCCS AOU di Bologna - Policlinico Sant'Orsola UO Oftalmologia
Bologna, Italy · Recruiting
Ospedale SS Annunziata, ASL 2 Lanciano Vasto Chieti
Chieti, Italy · Recruiting
Azienda Ospedaliero Universitaria Careggi
Florence, Italy · Recruiting
Fondazione Policlinico Universitario Campus Bio-Medico
Roma, Italy · Recruiting
AOU Policlinico Umberto I
Roma, Italy · Recruiting
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy · Recruiting
METAVISION ARRUZAFA S.L. (Hospital Arruzafa)
Córdoba, Spain · Recruiting
Miranza Galicia
Santiago de Compostela, Spain · Recruiting
Fundación de Oftalmología Médica de la Comunitat Valenciana (FOM)
Valencia, Spain · Recruiting
OBA - Universidad de Valladolid
Valladolid, Spain · Recruiting
Hospital Universitario Miguel Servet
Zaragoza, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.